Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Accumulated OCI history
Currency unavailable · from the balance sheet
No Accumulated OCI data reported for this period type.
Accumulated OCI vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.92M USD | +173.2% | — | 1.4% | |
| Mar 2026 | $212K USD | -44.6% | — | 0.0% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $208K USD | +1464788732394466.3% | — | 0.1% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $0 USD | +100.0% | — | 0.0% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | -$253K USD | -248.8% | — | 0.1% |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | -$505K USD | -431.6% | — | 0.1% |
| Mar 2026 | -$883K USD | -1138.8% | — | 0.2% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -44.6% | — | 0.1% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.